The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech
Stock and Other Ownership Interests - Roche
Correlation of measurements of tumor heterogeneity based on next-generation sequencing (NGS) of circulating tumor DNA (ctDNA) with clinical outcomes in STEAM, a prospective, randomized, multicenter study in metastatic colorectal cancer (mCRC).
 
Stephanie Yaung
Employment - Roche
Patents, Royalties, Other Intellectual Property - Roche
 
Nalin Tikoo
Employment - Roche
Stock and Other Ownership Interests - BeiGene; Celgene; Denali Therapeutics; Exelixis; Gilead Sciences
Travel, Accommodations, Expenses - Roche
 
Alan Nicholas
Employment - Genentech
Stock and Other Ownership Interests - Genentech
 
Nicolas Sommer
No Relationships to Disclose
 
Johanna C. Bendell
Research Funding - Abbott/AbbVie (Inst); Agios (Inst); Apexigen (Inst); ARMO BioSciences (Inst); Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); Celldex (Inst); CytomX Therapeutics (Inst); Daiichi Sankyo (Inst); Eisai (Inst); EMD Serono (Inst); EMD Serono (Inst); Evelo Therapeutics (Inst); Five Prime Therapeutics (Inst); FORMA Therapeutics (Inst); Forty Seven (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Gritstone Bio (Inst); Incyte (Inst); Ipsen (Inst); Kolltan Pharmaceuticals (Inst); Leap Therapeutics (Inst); Lilly (Inst); Macrogenics (Inst); Marshall Edwards (Inst); Merck (Inst); Merrimack (Inst); Mersana (Inst); Merus (Inst); Nektar (Inst); Novartis (Inst); Oncogenex (Inst); OncoMed (Inst); Onyx (Inst); Pieris Pharmaceuticals (Inst); Sanofi (Inst); Stem CentRx (Inst); SynDevRx (Inst); Taiho Pharmaceutical (Inst); Takeda (Inst); Tarveda Therapeutics (Inst); TG Therapeutics (Inst); Tyrogenex (Inst)
 
Herbert Hurwitz
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
Honoraria - Genentech/Roche
Consulting or Advisory Role - Genentech/Roche
Research Funding - Genentech/Roche (Inst); medpacto (Inst); NIH (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on patents for treatment of HFS
 
Richard Price
Employment - Genentech/Roche
Stock and Other Ownership Interests - Genentech/Roche
 
John F. Palma
Employment - Roche
Stock and Other Ownership Interests - Clovis Oncology; Exact Sciences; Johnson & Johnson; Roche
 
John J. Lee
Employment - Roche
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Patents Pending
Travel, Accommodations, Expenses - Roche
 
Fergal Casey
Employment - Roche
Stock and Other Ownership Interests - Novartis